2197 — Clover Biopharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for Clover Biopharmaceuticals, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,866	1,641	766	428	286
Net Total Accounts Receivable
Net Total Receivables	99.6	43.4	62	53.5	0.003
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	5,076	4,390	1,900	663	336
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	222	242	162	116	94.5
Net Intangible Assets
Other Long Term Assets
Total Assets	5,346	4,695	2,101	813	458
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,148	2,829	2,277	1,908	1,751
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	4,127	5,363	2,834	2,449	2,255
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,219	-668	-733	-1,636	-1,797
Total Liabilities & Shareholders' Equity	5,346	4,695	2,101	813	458
Total Common Shares Outstanding